Hlo
Give management of TRALI AMD TACO according to guidlines
TRALI TACO transfusion management guidelines
| Step | Action |
|---|---|
| 1. Stop transfusion | Immediately discontinue the offending blood product |
| 2. Notify blood bank | Report the reaction; retain the blood product for investigation |
| 3. Oxygen supplementation | Administer high-flow oxygen; target SpO2 >90% |
| 4. Supportive ventilation | If respiratory failure occurs, initiate mechanical ventilation with: - Low tidal volume (lung-protective) strategy - Maximize PEEP - Avoid volume overload |
| 5. Avoid diuretics | Unlike TACO, diuretics are generally NOT indicated (non-cardiogenic mechanism) |
| 6. Rule out other causes | Sepsis, cardiac ischemia, ARDS, fluid overload (check BNP, troponin, cultures) |
| 7. Lab investigations | Leukopenia, mild thrombocytopenia may be present; no specific confirmatory test is widely available |
Prevention is the best treatment: Use male-only donors for platelets and FFP, pre-storage leukoreduction (LR), solvent-detergent-treated plasma, and defer donors with high antibody titers or history of pregnancy/prior transfusion.
| Step | Action |
|---|---|
| 1. Stop transfusion | Immediately discontinue the transfusion product |
| 2. Notify blood bank | Report the reaction |
| 3. Oxygen supplementation | Administer oxygen; target adequate SpO2 |
| 4. Diuretics | Furosemide (key treatment) - to reverse volume overload; this is the most important management step |
| 5. Ventilatory support | If severe, provide mechanical ventilation (approximately 70% of TACO patients require it) |
| 6. Monitor and investigate | Check BNP/NT-proBNP (typically elevated), ECG, troponin to rule out ischemia |
| Feature | TRALI | TACO |
|---|---|---|
| Mechanism | Non-cardiogenic (immune-mediated capillary leak) | Cardiogenic (volume/pressure overload) |
| Blood pressure | Hypotension (common) | Hypertension |
| Pulmonary edema | Non-cardiogenic | Cardiogenic (hydrostatic) |
| BNP/NT-proBNP | Normal or mildly elevated | Markedly elevated |
| Response to diuretics | No benefit | Improves with diuretics |
| JVP/CVP | Normal or low | Elevated |
| Most common products | FFP, Platelets | Any blood product (large volume) |
| Diuretics in treatment | Avoid | Essential |
| Corticosteroids | May be considered in severe cases | Not indicated |